title: Chemogenomic analysis identifies Macbecin II as a compound specific for SMAD4-negative colon cancer cells.
authors.affiliation: Pharmaceutical Genomics Division, The Translational Genomics Research Institute, Scottsdale, AZ 85259, USA.
authors.forename: Christine
authors.initials: C
authors.lastname: Kaiser
authors.forename: Nathalie
authors.initials: N
authors.lastname: Meurice
authors.forename: Irma M
authors.initials: IM
authors.lastname: Gonzales
authors.forename: Shilpi
authors.initials: S
authors.lastname: Arora
authors.forename: Christian
authors.initials: C
authors.lastname: Beaudry
authors.forename: Kristen M
authors.initials: KM
authors.lastname: Bisanz
authors.forename: Alexander C
authors.initials: AC
authors.lastname: Robeson
authors.forename: Joachim
authors.initials: J
authors.lastname: Petit
authors.forename: David O
authors.initials: DO
authors.lastname: Azorsa